Synageva moves headquarters to Lexington, Mass.

09/17/2010 | Boston Globe (tiered subscription model), The

Synageva BioPharma has transferred its headquarters to a larger facility in Lexington, Mass., to provide more space for the development of its experimental drugs for rare diseases. One of the drugs included in the company's pipeline is SBC-102, an enzyme replacement treatment for lysosomal acid lipase deficiency.

View Full Article in:

Boston Globe (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Wayzata, MN
Meridian Health Plan
Detroit, MI